PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34850210-9	2022	CONCLUSIONS: Treatment with remdesivir leads to a 35.9% reduction in LCS rate in follow-up.	remdesivir	28-38	LCS1	Homo sapiens	69-72